Scientists find 1 way resveratrol acts to combat diseases, cancers
Scientists hoping to mimic the life-extending qualities produced by a chemical found in red wine and dark chocolate say they have solved one of the mysteries about how this compound works to combat the effects of obesity, diabetes, certain cancers and a host of other maladies.
The findings, published in Friday's edition of the journal Science, could lay the foundation for a variety of drugs that act like concentrated amounts of resveratrol, the compound that has inspired a $30-million-a-year supplement business. Pharmaceutical giants have invested millions of dollars in the quest to improve on the compound that helps rev up the body's cellular defenses against disease and aging.
Harvard geneticist David Sinclair and his colleagues have been working for more than a decade to uncover a chemical link between resveratrol and a group of enzymes known as sirtuins, which can trigger proteins that rejuvenate cells. The new results will help achieve a “more rational design” of resveratrol-related drugs, Sinclair said.
“We were working in the dark before,” he said.
Sinclair's resveratrol-related research has vaulted him to rock-star status by the standards of biochemists. He has sipped wine on “Nightline” and “60 Minutes” and presented his work at industry conferences. In 2008, GlaxoSmithKline paid $720 million for Sirtris, the biotech firm he cofounded to commercialize his discoveries. He remains on the company's scientific advisory board.
But Sinclair's results touched off an academic imbroglio, some of it fueled by rival pharmaceutical companies.
Scientists on both sides reacted with enthusiasm to the latest resveratrol findings, saying they would lay to rest a key disagreement, even if they won't dispel skepticism about the possibility for a pharmaceutical fountain of youth.
“We've known that it's true in the test tube,” said Matt Kaeberlein, a University of Washington biogerontologist who has questioned some of Sinclair's studies. “What this does is suggest the same thing is true in cells.”
“This is not weak evidence at this point,” said Leonard Guarente, a biologist at the Massachusetts Institute of Technology who trained Sinclair and several of his critics. “You would really bet the ranch on this one.” Guarente also serves on the Sirtris scientific advisory board.
The latest advance by Sinclair's team isn't likely to have the mass appeal of earlier studies that showed resveratrol could improve heart function in people, make obese mice as nimble as thin ones and cause flies, fish and worms to live longer. Those splashy results fueled the rise of high-dose resveratrol supplements, which have not been vetted.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Postal Service falls short of slower mail delivery standards
- CDC lauds schools for better nutrition
- Memorial service for slain Virginia journalists brings call for action
- University of Texas removes statue of Confederate President Davis
- Motive in ambush of Houston area deputy remains unknown
- Obama administration developing sanctions against China over cyberespionage
- Erika wanes as Tropical Storm Fred forms in Atlantic
- New Orleans slow to heal 10 years after Hurricane Katrina
- Obama inches closer to veto-proof support for Iran nuclear deal
- Pope Francis’ lack of familiarity with United States unusual
- Supreme Court can resolve Kentucky county clerk’s refusal to issue marriage licenses to gays